Source comparison
Sermorelin Help Recovery Research: Clinical vs Preclinical Comparison
Preclinical (rodent) Surgical wound closure Time to 90% epithelialization 32% faster vs control (p<0.01) IGF-1 elevation, collagen synthesis upregulation Strong mechanistic support; translational uncertainty moderate Preclinical (canine) Post-operative activit
This comparison does not assign a generated winner or score.
- Preclinical (rodent)
- Surgical wound closure
- Time to 90% epithelialization
- 32% faster vs control (p<0.01)
- IGF-1 elevation, collagen synthesis upregulation
- Strong mechanistic support; translational uncertainty moderate
- Preclinical (canine)
- Post-operative activity recovery
- Days to baseline mobility
- 18% reduction vs placebo
- Cortisol suppression, IGF-1 increase
- Relevant for veterinary application; human extrapolation limited
- Phase II (human)
- Exercise-induced muscle damage
- Creatine kinase clearance rate
- 22% faster vs placebo (p=0.04)
- Presumed GH-IGF-1 axis; direct tissue measurement absent
- Promising but underpowered; needs replication in dedicated injury trial
- In vitro (myoblast culture)
- Proliferation rate post-serum starvation
- Cell doubling time
- 27% reduction with sermorelin exposure
- mTOR activation confirmed via Western blot
- Mechanistic validation; no in vivo context